This New Year’s Eve, I am going to drink a toast to a new era in the use of CTPs, based on data around real-world clinical effectiveness.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

The CMS newsroom just released this press release yesterday, announcing that Final Local Coverage Determinations (LCDs) for Certain Skin Substitutes Have Been Withdrawn.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

I asked Dermatologist Dr. Alex Ortega Loayza to explain Biologics License Application (BLA) products, and he provided this guest post.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

Last week at the Desert Foot meeting, I had the extraordinary honor of being the 13th recipient of the Paul Brand Award from Dr. Robert Frykberg, who began the tradition.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

The LCDs provide access to multiple evidence-based skin substitute products for Medicare beneficiaries with diabetic foot ulcers and venous leg ulcers.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

The sad fact is that the most important reforms in wound care payment policy have not happened yet. But this is a start.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

Vohra will enter into a Corporate Integrity Agreement with the Office of Inspector General for the Department of Health and Human Services.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

Every minute you spend providing and documenting high quality care is an hour you will not have to spend defending your payments.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

The comprehensive rebuke of the auditors’ decisions by this very thoughtful Administrative Law Judge seems important.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

Wound care practitioners who want to do the right thing for patients can succeed. Stay tuned for more.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.